Professional Overview
Dean Hodgson is a seasoned life sciences executive with over 20 years of experience in technical operations, external manufacturing, and quality assurance. As the Vice President of Technical Operations at OncoNano Medicine, Inc., he leads the company's manufacturing, supply chain, and quality functions, driving innovation and efficiency to support the development and commercialization of novel cancer therapeutics.
Experience Summary
Current Role
As Vice President of Technical Operations at OncoNano Medicine, Inc., Dean is responsible for overseeing all aspects of the company's manufacturing, supply chain, and quality operations. He collaborates closely with cross-functional teams to ensure the seamless delivery of clinical trial materials and the successful scale-up and commercialization of OncoNano's pipeline of oncology products. Under his leadership, the technical operations team has achieved significant improvements in productivity, cost savings, and regulatory compliance.
Career Progression
Prior to joining OncoNano, Dean held various leadership roles in external manufacturing and quality assurance at Gilead Sciences, Immunomedics, and Juno Therapeutics. He has a proven track record of driving operational excellence and implementing innovative strategies to enhance manufacturing capabilities and supply chain resilience. Dean's deep understanding of the biopharmaceutical industry and expertise in navigating complex regulatory environments have been instrumental in his career progression.
Academic Background
Dean holds a Bachelor of Science in Biology from the University of California, Los Angeles, and a Master of Science in Biomedical Engineering from the University of Southern California. He is a skilled problem-solver with a strong foundation in scientific principles and a commitment to continuous learning.
Areas of Expertise
- Technical operations management
- External manufacturing and strategic sourcing
- Quality assurance and regulatory compliance
- Biopharmaceutical process development and scale-up
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Dean has made significant contributions to the success of his organizations. At Gilead Sciences, he led the implementation of a comprehensive quality management system that improved compliance and reduced audit findings by 30%. At Immunomedics, he spearheaded the successful transfer and scale-up of a critical antibody-drug conjugate manufacturing process, enabling the company to accelerate its clinical development timeline.
Conclusion
With his extensive industry experience, technical expertise, and strategic vision, Dean Hodgson is well-positioned to drive the continued success of OncoNano Medicine as it advances its pipeline of innovative cancer therapies. His leadership and commitment to excellence make him a valuable asset to the company and the broader biopharmaceutical community.
